Side-by-side comparison of AI visibility scores, market position, and capabilities
Xylem Inc. (XYL) reported ~$8.3B revenue in FY2024. Global water technology company providing pumps, treatment systems, and smart water infrastructure for utilities and industrial users. HQ: Washington, DC.
Xylem Inc. is a global water technology company providing equipment and services for water and wastewater applications across utilities, industrial, commercial, and residential end markets. Spun off from ITT Corporation in 2011, Xylem designs and manufactures pumps, mixers, water quality testing equipment, analytics platforms, and advanced metering infrastructure (AMI) used to move, treat, measure, and manage water and wastewater. The company's 2023 acquisition of Evoqua Water Technologies for $7.5 billion significantly expanded its water treatment capabilities.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.